Venetoclax and Decitabine in Pediatric Refractory T-cell Lymphoblastic Lymphoma

Conclusion: This case highlights the potential clinical activity of venetoclax and decitabine in relapsed T-LL.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Clinical and Laboratory Observations Source Type: research